[5] Her research in the Centro de Investigación y de Estudios Avanzados[6][7] del IPN (México) is focused on the molecular biology and genetics of Entamoeba histolytica, mainly in the genes and proteins that drive the virulence mechanisms of this human parasite, willing to develop a vaccine and more efficient treatments against amoebiasis.

Since 1990 she works in the Department of Infectomics and Molecular Pathogenesis (formerly Experimental Pathology) of this research center based in Mexico City.

[21] She was the founder and, from 2006 to 2010, General Director the Institute of Science and Technology of Mexico City (ICyTDF), during the administration of Marcelo Ebrard Casaubon (former Head of Government).

The ICyTDF was conceived as a public body to “promote the use of science and technology for contribute to the solution of the problems of the Mexican capital and the welfare of the population; promote local science; act as an articulating link between the Mexico City government agencies and scientific and technological research groups, the social, educational and business sectors, as well as increase a scientific culture in society.

During this period, she coordinated the technical-scientific group representing Mexico in the Coalition for Epidemic Preparedness Innovations (CEPI), which was formed in collaboration with universities, research centers and national companies to face the COVID-19 pandemic.

Through this consortium, funding was obtained from international cooperation resources to accelerate Mexican projects aimed to develop diagnostics methods and vaccines against the SARS-CoV-2 virus.